Ferrán Algaba

17.6k total citations · 4 hit papers
190 papers, 9.8k citations indexed

About

Ferrán Algaba is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ferrán Algaba has authored 190 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Surgery, 84 papers in Pulmonary and Respiratory Medicine and 59 papers in Molecular Biology. Recurrent topics in Ferrán Algaba's work include Bladder and Urothelial Cancer Treatments (76 papers), Urinary and Genital Oncology Studies (62 papers) and Renal cell carcinoma treatment (44 papers). Ferrán Algaba is often cited by papers focused on Bladder and Urothelial Cancer Treatments (76 papers), Urinary and Genital Oncology Studies (62 papers) and Renal cell carcinoma treatment (44 papers). Ferrán Algaba collaborates with scholars based in Spain, Italy and United States. Ferrán Algaba's co-authors include Bernard Escudier, Camillo Porta, Vincent Khoo, Manuela Schmidinger, Jean Jacques Patard, Timothy Eisen, Alan Horwich, Rodolfo Montironi, Giorgio Pizzocaro and M. Pilar Laguna and has published in prestigious journals such as PLoS ONE, Cancer and Clinical Cancer Research.

In The Last Decade

Ferrán Algaba

183 papers receiving 9.6k citations

Hit Papers

Renal cell carcinoma: ESMO Clinical Practice Guid... 2005 2026 2012 2019 2014 2005 2013 2015 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferrán Algaba Spain 44 5.4k 4.2k 3.4k 1.6k 1.4k 190 9.8k
Daniel M. Berney United Kingdom 53 3.7k 0.7× 5.5k 1.3× 3.6k 1.1× 1.6k 1.0× 2.4k 1.7× 250 10.2k
Paul Perrotte Canada 60 5.0k 0.9× 7.7k 1.8× 3.5k 1.0× 3.2k 2.0× 1.8k 1.2× 311 12.6k
Maria De Santis Italy 46 6.2k 1.2× 2.2k 0.5× 1.8k 0.5× 2.5k 1.6× 808 0.6× 217 10.2k
Andrew J. Stephenson United States 51 3.4k 0.6× 7.7k 1.8× 1.7k 0.5× 1.2k 0.7× 1.4k 1.0× 242 10.5k
Patrick J. Bastian Germany 58 4.7k 0.9× 4.6k 1.1× 2.8k 0.8× 1.4k 0.9× 1.5k 1.1× 188 10.4k
Arthur I. Sagalowsky United States 58 7.8k 1.5× 3.7k 0.9× 3.2k 0.9× 2.4k 1.5× 1.1k 0.8× 285 12.2k
Vitaly Margulis United States 47 5.6k 1.0× 4.1k 1.0× 2.4k 0.7× 1.5k 0.9× 1.2k 0.8× 360 8.9k
John R. Srigley Canada 58 3.6k 0.7× 11.1k 2.6× 5.0k 1.5× 2.1k 1.3× 2.3k 1.6× 221 14.7k
Jean B. deKernion United States 61 3.1k 0.6× 8.9k 2.1× 4.0k 1.2× 2.8k 1.8× 1.9k 1.3× 219 13.1k
Mitchell C. Benson United States 52 3.1k 0.6× 8.6k 2.1× 3.9k 1.1× 2.8k 1.8× 2.2k 1.6× 268 13.3k

Countries citing papers authored by Ferrán Algaba

Since Specialization
Citations

This map shows the geographic impact of Ferrán Algaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferrán Algaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferrán Algaba more than expected).

Fields of papers citing papers by Ferrán Algaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferrán Algaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferrán Algaba. The network helps show where Ferrán Algaba may publish in the future.

Co-authorship network of co-authors of Ferrán Algaba

This figure shows the co-authorship network connecting the top 25 collaborators of Ferrán Algaba. A scholar is included among the top collaborators of Ferrán Algaba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferrán Algaba. Ferrán Algaba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basile, Giuseppe, Andrea Gallioli, Alberto Martini, et al.. (2024). Oncologic surveillance intensity after endoscopic treatment of upper tract urothelial carcinoma. Minerva Urology and Nephrology. 76(1). 88–96. 1 indexed citations
2.
Baboudjian, Michaël, Angelo Territo, Andrea Gallioli, et al.. (2023). Long-Term Oncologic Outcomes of Endoscopic Management of High-Risk Upper Tract Urothelial Carcinoma: The Fundació Puigvert's Experience. Journal of Endourology. 37(9). 973–977. 10 indexed citations
3.
Gallioli, Andrea, Giuseppe Basile, Angelo Territo, et al.. (2023). The importance of second-look ureteroscopy implementation in the conservative management of upper tract urothelial carcinoma. World Journal of Urology. 41(10). 2743–2749. 8 indexed citations
4.
Gaya, Josep María, Giuseppe Basile, Andrea Gallioli, et al.. (2023). Simultaneous Bilateral Video–Endoscopic Inguinal Lymphadenectomy for Penile Carcinoma: Surgical Setting, Feasibility, Safety, and Preliminary Oncological Outcomes. Journal of Clinical Medicine. 12(23). 7272–7272. 1 indexed citations
6.
Escudier, Bernard, Tim Eisen, Camillo Porta, et al.. (2012). Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 23. vii65–vii71. 231 indexed citations
7.
Pardo, Pablo, Óscar Rodríguez-Faba, Joan Palou, et al.. (2012). Relevance of the clinical–pathological predictive factors in force in chromophobe renal cell cancer. Actas Urológicas Españolas (English Edition). 36(9). 527–531.
8.
López-Beltrán, Antonio, Ziya Kırkalı, Rodolfo Montironi, et al.. (2012). Unclassified renal cell carcinoma: a report of 56 cases. British Journal of Urology. 110(6). 786–793. 21 indexed citations
9.
Albers, Peter, W. Albrecht, Ferrán Algaba, et al.. (2010). Guía clínica sobre el cáncer de testículo. 2 indexed citations
10.
Cebrián, Virginia, Virginia López, Esteban Orenes‐Piñero, et al.. (2008). Identification of PMF1 Methylation in Association with Bladder Cancer Progression. Clinical Cancer Research. 14(24). 8236–8243. 29 indexed citations
12.
Huguet, J., Sergi Sabaté, Óscar Rodríguez-Faba, et al.. (2007). Diagnosis, Risk Factors, and Outcome of Urethral Recurrences Following Radical Cystectomy for Bladder Cancer in 729 Male Patients. European Urology. 53(4). 785–793. 41 indexed citations
13.
Marín‐Aguilera, Mercedes, Lourdes Mengual, María J. Ribal, et al.. (2006). Utility of Fluorescence In Situ Hybridization as a Non-invasive Technique in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma. European Urology. 51(2). 409–415. 57 indexed citations
14.
Montironi, Rodolfo, Roberta Mazzucchelli, Marina Scarpelli, et al.. (2006). Prostate carcinoma II: prognostic factors in prostate needle biopsies. British Journal of Urology. 97(3). 492–497. 29 indexed citations
15.
Algaba, Ferrán, et al.. (2003). Schwannoma of the Penis: A Report of 2 Cases. Journal of Andrology. 24(5). 651–652. 9 indexed citations
16.
Algaba, Ferrán, Isabel Trias, Marina Scarpelli, et al.. (2003). Handling and Pathology Reporting of Renal Tumor Specimens. European Urology. 45(4). 437–443. 37 indexed citations
17.
Laguna, M. Pilar, et al.. (2001). EAU Guidelines on Testicular Cancer. European Urology. 40(2). 102–110. 111 indexed citations
18.
Algaba, Ferrán, Jonathan I. Epstein, Hector C. Aldape, et al.. (1996). Workgroup 5: Assessment of prostate carcinoma in core needle biopsy‐‐Definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer. 78(2). 376–381. 1 indexed citations
19.
Vicente, J., Jorge A. R. Salvador, Pilar Laguna, & Ferrán Algaba. (1991). Histological Evaluation of Superficial Bladder Tumors Treated byNd-YAG Laser and Transurethral Resection. European Urology. 20(3). 192–196. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026